A provisional agreement gives the European Chemicals Agency a standalone legal basis, unified budget and stronger conflict-of-interest rules. The reform acknowledges that EU chemicals policy is only credible if ECHA has the expertise and financial resilience to carry a rapidly growing workload.
The Council and European Parliament have reached a provisional agreement to strengthen the governance and funding of the European Chemicals Agency, as Brussels confronts growing pressure to prove that its chemicals legislation can be implemented as well as adopted.
The agreement creates a standalone legal framework for ECHA, separating its institutional basis from the REACH regulation under which the agency was established.
That change may sound administrative. In practice, it reflects a much larger problem: ECHA’s duties have expanded across multiple laws, while its funding, scientific committees and governance structure have struggled to keep pace.
One agency now carries several regulatory systems
ECHA is best known for its role in implementing REACH, the EU framework for registering, evaluating, authorising and restricting chemicals. It maintains extensive databases and provides scientific assessments used by the Commission and member states.
Its responsibilities now extend beyond the original REACH architecture into product safety and environmental policy. The agency produces or supports work on biocides, classification and labelling, microplastics, persistent chemicals and other files with major consequences for industry and consumers.
The provisional agreement consolidates those tasks under one autonomous regulation. That should make it clearer which duties belong to ECHA, how they are governed and what resources are required.
PFAS shows why capacity matters
The debate over per- and polyfluoroalkyl substances, commonly known as PFAS, illustrates the scale of the agency’s challenge. The substances are used across thousands of products and industrial processes, while evidence of persistence and environmental exposure has driven calls for broad restrictions.
Assessing such a file requires toxicology, exposure data, socio-economic analysis and detailed examination of possible alternatives. An under-resourced agency can produce delays that satisfy nobody: environmental and public-health groups wait for protection, while companies operate under prolonged regulatory uncertainty.
The same tension applies to microplastics and other high-volume files. Scientific rigour takes time, but delay becomes harder to defend when it results from vacant posts, unstable fee income or an overloaded committee system.
A single budget with a reserve
ECHA currently operates through several budgetary streams. The agreement replaces them with one autonomous budget, allowing resources to be shifted more flexibly as workloads change.
It also creates a reserve fund capped at 10% of income from fees and charges. The Commission will be able to adjust that share between 1% and 20% to reflect actual financial needs.
The reserve is intended to address a structural vulnerability. ECHA’s fee income can fluctuate as company registrations and regulatory activity change, while scientific work cannot simply stop when revenue falls.
Predictable EU funding remains essential. A reserve can absorb variation, but it should not become a substitute for matching new legal responsibilities with permanent staff and technical resources.
Member states must supply expertise
The agreement provides for a pool of experts nominated by member states and appointed to ECHA’s risk-assessment and socio-economic-analysis committees.
This distributes responsibility beyond Helsinki. National governments frequently demand faster assessments and clearer rules, but the agency depends on experts with specialised knowledge who may also be scarce inside national administrations.
The quality of nominations will matter as much as the number. Committee members must be able to evaluate complex industry data while remaining independent of political and commercial pressure.
The Parliament and member states will also be able to request scientific opinions from ECHA after consulting the Commission. That can make the agency more responsive, but it may increase workload if requests are not prioritised or accompanied by resources.
Independence becomes part of enforcement credibility
The provisional text introduces clearer rules for preventing and managing conflicts of interest among staff, experts and members of internal bodies.
Chemicals decisions can affect entire product categories and impose large costs. Industry needs confidence that restrictions are based on evidence rather than political pressure. Citizens need confidence that scientific opinions are not shaped by companies with financial interests in the outcome.
Transparency over declarations, recusals and the evidence considered will therefore be critical. Formal conflict rules are useful only if potential interests are identified early and decisions can withstand scrutiny.
Competitiveness and protection are not separate files
European manufacturers regularly warn that chemicals regulation is complex, slow and costly. Environmental groups respond that weak enforcement transfers health and clean-up costs to the public.
Both concerns point towards the same institutional need: capable, timely and predictable administration. A well-resourced agency can identify genuine risks more quickly, reject weak claims and give companies clearer timelines for substitution or compliance.
EU Today has reported how the supply of specialised chemical inputs such as nitrocellulose has become an industrial-security problem. That example concerns defence production rather than ECHA governance, but it demonstrates why chemicals policy now sits at the intersection of safety, supply resilience and strategic industry.
Rules that ignore industrial reality can create dependencies. Rules that ignore health and environmental evidence create liabilities that eventually become economic costs.
The deal is not yet final law
The provisional agreement must still be formally adopted by the Council and Parliament. The regulation will then enter into force 20 days after publication in the Official Journal.
The deeper test comes later. Brussels must show that the new structure reduces backlogs, improves the quality of opinions and provides enough certainty for companies making long-term investment decisions.
Reforming an agency’s budget rarely attracts the attention given to a chemicals ban. Yet the effectiveness of every future restriction, authorisation and scientific opinion will depend on the institution behind it.
The agreement is therefore an admission as well as a reform: Europe cannot continue expanding its chemicals rulebook without expanding the capacity required to administer it.
